推荐产品
ligand
recombinant protein L (E. coli), mammalian free
包裝
pack of 200 mL
製造商/商標名
Cytiva 17-5478-02
儲存條件
(20% Ehtanol)
基質
rigid, highly cross-linked agarose
樣品平均尺寸
85 μm (d₅₀v is the median particle size of the cumulative volume distribution)
工作範圍
2-10(pH interval where the medium can be operated without significant change in function.)
適合性
suitable for bioprocess medium
儲存溫度
2-8°C
一般說明
Capto™ L resin is designed for antibody fragment purification, when the fragment contains the kappa light chain.
Affinity resin for antibody fragment purification
Capto™ L combines a rigid, high-flow agarose matrix with the immunoglobulin-binding recombinant protein L ligand, which has a strong affinity to the variable region of antibody kappa light chains. The high binding capacity and affinity to a broad range of antibody fragments makes this resin an excellent capture platform for antibody fragments containing kappa light chains. Common uses include domain antibody (dAb), scFv, and Fab purification.
Using this protein L resin
Capto™ L resin requires minimal optimization and produces high purity in one separation step, resulting in significant savings during process development. This resin is also advantageous in manufacturing, because high selectivity of affinity capture reduces the number of subsequent polishing steps.
Affinity resin for antibody fragment purification
Capto™ L combines a rigid, high-flow agarose matrix with the immunoglobulin-binding recombinant protein L ligand, which has a strong affinity to the variable region of antibody kappa light chains. The high binding capacity and affinity to a broad range of antibody fragments makes this resin an excellent capture platform for antibody fragments containing kappa light chains. Common uses include domain antibody (dAb), scFv, and Fab purification.
Using this protein L resin
Capto™ L resin requires minimal optimization and produces high purity in one separation step, resulting in significant savings during process development. This resin is also advantageous in manufacturing, because high selectivity of affinity capture reduces the number of subsequent polishing steps.
應用
Purification of antibody fragments using affinity chromatography
特點和優勢
- Suitable for the capture of a wide range of antibody fragments such as Fabs, dAbs, and single-chain fragment variable (scFv) .
- High binding capacity, low ligand leakage, and selectivity for a broad range of antibody fragments reduces process time and amount of resin.
- Enables a platform approach to antibody fragment purification.Excellent productivity, process economy, and process design flexibility due to rigid matrix.
- Hydrophilic base matrix ensures low levels of non-specific binding and low levels of host cell-derived impurities in the elution pool.
- Fulfills industrial demands for security of supply, robust performance, and regulatory support.
儲存和穩定性
Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.
分析報告
To view the Certificate of Analysis for this product, please visit www.cytiva.com.
法律資訊
Capto is a trademark of Cytiva
訊號詞
Warning
危險聲明
儲存類別代碼
3 - Flammable liquids
实验方案
This page shows how to purify antibody fragments by affinity chromatography using Capto L products from GE Healthcare.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门